🕵️ Lexicon Pharmaceuticals, Inc. ($LXRX)
SEC insider & ownership activity, last 12 months · CIK 1062822 · every row links its SEC filing
Over the last 12 months insiders bought $2.7M with no open-market selling against it. Invus Global Management, LLC bought $2.0M in discretionary trades (Feb). Invus Global Management, LLC trimmed 10.0% → 9.6%. No red-flag 8-Ks in the window.
Insider flow
2 buyers, $2.7M (8 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Invus Global Management, LLC | 1 | $2.0M | 0 | – | Feb 2, 2026 |
| Debbane Raymond | 7 | $723K | 0 | – | Feb 25, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Artal Participations S.a R.l. | 39.4% | 13D | Apr 30, 2026 | filing ↗ | |
| Artal International S.c.a. | 39.4% | 13D | Apr 30, 2026 | filing ↗ | |
| Artal International Management S.A. | 39.4% | 13D | Apr 30, 2026 | filing ↗ | |
| Artal Group S.A. | 39.4% | 13D | Apr 30, 2026 | filing ↗ | |
| Westend S.a. | 39.4% | 13D | Apr 30, 2026 | filing ↗ | |
| Stichting Administratiekantoor Westend | 39.4% | 13D | Apr 30, 2026 | filing ↗ | |
| Amaury Wittouck | 39.4% | 13D | Apr 30, 2026 | filing ↗ | |
| Mr. Amaury Wittouck | 36.2% | 13D | Jan 29, 2026 | filing ↗ | |
| Mr. Raymond Debbane | 12.0% | 13D | Jan 29, 2026 | filing ↗ | |
| Raymond Debbane | 11.7% | 13D | Apr 30, 2026 | filing ↗ | |
| FMR LLC | 10.5% | 13G | Jul 8, 2025 | filing ↗ | |
| Abigail P. Johnson | 10.5% | 13G | Jul 8, 2025 | filing ↗ | |
| Invus, L.P. | 10.0% | 13D | Jan 29, 2026 | filing ↗ | |
| Invus, L.P. | 9.6% | 13D | Apr 30, 2026 | filing ↗ | |
| Invus Advisors, L.L.C. | 9.6% | 13D | Apr 30, 2026 | filing ↗ | |
| Siren, L.L.C. | 9.6% | 13D | Apr 30, 2026 | filing ↗ | |
| Invus Global Management, LLC | 9.6% | 13D | Apr 30, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Material agreement (1.01) | May 4, 2026 | filing ↗ |
| New financial obligation (2.03) | May 4, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | May 4, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 4, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 30, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Apr 30, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Apr 30, 2026 | filing ↗ |
| Shareholder vote (5.07) | Apr 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 30, 2026 | filing ↗ |
| Earnings (2.02) | Mar 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 5, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 29, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jan 29, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Jan 29, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jan 29, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 29, 2026 | filing ↗ |
| Earnings (2.02) | Jan 29, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 29, 2026 | filing ↗ |
| Other events (8.01) | Jan 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 29, 2026 | filing ↗ |
| Other events (8.01) | Nov 6, 2025 | filing ↗ |
| Other events (8.01) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Earnings (2.02) | Aug 6, 2025 | filing ↗ |